AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8834128 — intervention group
Group type: COMPARATOR
Intervention: Standard pharmacological treatment (prednisone 10‐15 mg/day) alone for 4 years
Number of subjects: 18
Study 2473061 — intervention group
Group type: EXPERIMENTAL
Intervention: MOPP chemotherapy
Number of subjects: 0
Study 2473061 — intervention group
Group type: EXPERIMENTAL
Intervention: MOPP/ABVD, CAD/MOPP/ABV, MOPP/ABV
Number of subjects: 0
Study 2473061 — intervention group
Group type: COMPARATOR
Intervention: Limited adjuvant RT
Number of subjects: 0
Study 2473061 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive chemotherapy and RT with cytokines
Number of subjects: 0
Study 2473061 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous bone marrow transplantation
Number of subjects: 0
Study 2473061 — intervention group
Group type: EXPERIMENTAL
Intervention: Reducing morbidity without adverse prognostic factors
Number of subjects: 0
Study 903604 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychologically differentiated subjects under 5% probability of noise
Number of subjects: 0
Study 903604 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychologically differentiated subjects under 50% probability of noise
Number of subjects: 0
Study 903604 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychologically differentiated subjects under 95% probability of noise
Number of subjects: 0
Study 903604 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychologically nondifferentiated subjects under 5% probability of noise
Number of subjects: 0
Study 903604 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychologically nondifferentiated subjects under 50% probability of noise
Number of subjects: 0
Study 903604 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychologically nondifferentiated subjects under 95% probability of noise
Number of subjects: 0
Study 31121331 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular injection of a mixture of 0.5ml hyaluronic acid and 0.5ml corticosteroid
Number of subjects: 16
Study 31121331 — intervention group
Group type: COMPARATOR
Intervention: Arthrocentesis with Ringer solution
Number of subjects: 16
Study 28842164 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based intervention by academic health professionals (Arm 2)
Number of subjects: 330
Study 28842164 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based intervention by lay health workers (Arm 1)
Number of subjects: 330
Study 28842164 — intervention group
Group type: COMPARATOR
Intervention: Control group (Arm 3)
Number of subjects: 330
Study 28318797 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (N=33)
Number of subjects: 174
Study 28318797 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (N=51)
Number of subjects: 174
Study 28318797 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 174
Study 25913263 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal unlocked nailing
Number of subjects: 70
Study 25913263 — intervention group
Group type: COMPARATOR
Intervention: Distal locked nailing
Number of subjects: 70
Study 25913263 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (locking and unlocking)
Number of subjects: 70
Study 23378346 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratympanic steroid (prednisolone) administered daily for 3 consecutive days
Number of subjects: 50
Study 23378346 — intervention group
Group type: COMPARATOR
Intervention: Control (saline solution) administered daily for 3 consecutive days
Number of subjects: 50
Study 23378346 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratympanic steroid (prednisolone)
Number of subjects: 50
Study 21227013 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 40
Study 21227013 — intervention group
Group type: COMPARATOR
Intervention: Open cholecystectomy (OC)
Number of subjects: 40
Study 17487577 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis use
Number of subjects: 404
Study 17487577 — intervention group
Group type: COMPARATOR
Intervention: Heavy alcohol use
Number of subjects: 404
Study 16808624 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose group (internal dose median 168 mSv, external dose median 280 mSv)
Number of subjects: 47
Study 16808624 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose group (internal dose negligible, external dose median 22 mSv)
Number of subjects: 47
Study 16808624 — intervention group
Group type: COMPARATOR
Intervention: Control group (no history of occupational radiation exposure)
Number of subjects: 47
Study 16808624 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose group
Number of subjects: 47
Study 16808624 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose group, Low-dose group, Control group
Number of subjects: 47
Study 15526507 — intervention group
Group type: EXPERIMENTAL
Intervention: Rovamycine 12 days 4.5 MUI iv/day as add-on therapy
Number of subjects: 109
Study 15526507 — intervention group
Group type: EXPERIMENTAL
Intervention: Rovamycine 12 days 4.5 MUI iv/day followed by 6 MUI/day per os for another 12 days add-on treatment
Number of subjects: 109
Study 11051946 — intervention group
Group type: EXPERIMENTAL
Intervention: Winged Vialon cannulae
Number of subjects: 42
Study 11051946 — intervention group
Group type: COMPARATOR
Intervention: Metal butterfly needles
Number of subjects: 42
Study 8630132 — intervention group
Group type: EXPERIMENTAL
Intervention: Buffered lidocaine at body temperature (37 degrees C)
Number of subjects: 40
Study 8630132 — intervention group
Group type: COMPARATOR
Intervention: Buffered lidocaine at room temperature (20 degrees C)
Number of subjects: 40
Study 1734586 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy with a field size of 5 x 5 cm2
Number of subjects: 116
Study 1734586 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy with a field size of 6 x 6 cm2
Number of subjects: 116
Study 6699425 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 8-methoxypsoralen (8-MOP) with small doses of UVA irradiation
Number of subjects: 0
Study 6699425 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 31791376 — intervention group
Group type: EXPERIMENTAL
Intervention: First line antihypertensive treatment
Number of subjects: 1200
Study 31791376 — intervention group
Group type: EXPERIMENTAL
Intervention: Interim sample size reassessment
Number of subjects: 1200
Study 31791376 — intervention group
Group type: COMPARATOR
Intervention: Sample size of 600 participants
Number of subjects: 1200
Study 29986900 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupuncture (AA) applied bilaterally at specific points the day before surgery.
Number of subjects: 62
Study 29986900 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group).
Number of subjects: 62
Study 27222759 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive distraction (listening to a song on headphones)
Number of subjects: 90
Study 27222759 — intervention group
Group type: EXPERIMENTAL
Intervention: Active distraction (moving legs up and down)
Number of subjects: 90
Study 27222759 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive-active distraction (combination of both techniques)
Number of subjects: 90
Study 24021029 — intervention group
Group type: EXPERIMENTAL
Intervention: SumaRT/Nap (85 mg sumatriptan + 500 mg naproxen sodium)
Number of subjects: 32
Study 24021029 — intervention group
Group type: COMPARATOR
Intervention: Naproxen sodium (500 mg)
Number of subjects: 32
Study 21384431 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine treatment in mild AD patients
Number of subjects: 0
Study 21384431 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine treatment in moderate AD patients
Number of subjects: 0
Study 21384431 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study 20375338 — intervention group
Group type: EXPERIMENTAL
Intervention: Monovision contact lenses (MV)
Number of subjects: 11
Study 20375338 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifocal contact lenses (MTF CL)
Number of subjects: 11
Study 20375338 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-vision distance lenses (SV)
Number of subjects: 11
Study 17851346 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal irrigation
Number of subjects: 9
Study 16215966 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial Neural Network (ANN) classifier with features selected by POE+ACC
Number of subjects: 63
Study 16215966 — intervention group
Group type: EXPERIMENTAL
Intervention: k-nearest-neighbor (k-NN) classifier
Number of subjects: 63
Study 16215966 — intervention group
Group type: EXPERIMENTAL
Intervention: Texture analysis (TA) of ROIs in bone marrow and fat tissue
Number of subjects: 63
Study 12126338 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 50
Study 12126338 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 10418585 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Nissen fundoplication
Number of subjects: 17
Study 10418585 — intervention group
Group type: COMPARATOR
Intervention: Conventional Nissen fundoplication
Number of subjects: 17
Study 10418585 — intervention group
Group type: EXPERIMENTAL
Intervention: Both laparoscopic and conventional Nissen fundoplication
Number of subjects: 17
Study 7676389 — intervention group
Group type: EXPERIMENTAL
Intervention: Low fluoride containing toothpaste (250 ppm F)
Number of subjects: 16
Study 7676389 — intervention group
Group type: COMPARATOR
Intervention: Placebo toothpaste (non F-toothpaste)
Number of subjects: 16
Study 1693065 — intervention group
Group type: EXPERIMENTAL
Intervention: Inosine pranobex (3 g/day)
Number of subjects: 50
Study 1693065 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 1693065 — intervention group
Group type: EXPERIMENTAL
Intervention: Inosine pranobex
Number of subjects: 50
Study 7290868 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness training plus regulated‐breathing method
Number of subjects: 16
Study 7290868 — intervention group
Group type: COMPARATOR
Intervention: Regulated‐breathing method only
Number of subjects: 16
Study 30922128 — intervention group
Group type: EXPERIMENTAL
Intervention: Early inhaled bronchodilators
Number of subjects: 863
Study 30922128 — intervention group
Group type: COMPARATOR
Intervention: No bronchodilators
Number of subjects: 863
Study 28287004 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab (60 mg)
Number of subjects: 50
Study 28287004 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 26463242 — intervention group
Group type: EXPERIMENTAL
Intervention: Transoral incisionless fundoplication (TIF2) procedure
Number of subjects: 44
Study 26463242 — intervention group
Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 44
Study 23615131 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG IFNα‐2a (135 μg once weekly) plus lamivudine (100 mg daily)
Number of subjects: 47
Study 23615131 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG IFNα‐2a (135 μg once weekly) plus adefovir (10 mg daily)
Number of subjects: 47
Study 21391940 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity physical activity intervention (PA)
Number of subjects: 424
Study 21391940 — intervention group
Group type: COMPARATOR
Intervention: Successful aging control (SA)
Number of subjects: 424
Study 19808840 — intervention group
Group type: COMPARATOR
Intervention: 17beta-estradiol (E(2)) supplementation
Number of subjects: 24
Study 19808840 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute exercise
Number of subjects: 24
Study 19808840 — intervention group
Group type: COMPARATOR
Intervention: Menstrual cycle phase (midfollicular and midluteal)
Number of subjects: 24
Study 19808840 — intervention group
Group type: COMPARATOR
Intervention: Sex (men vs women)
Number of subjects: 24
Study 17685744 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline plus ziprasidone 80 mg/day
Number of subjects: 64
Study 17685744 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline plus ziprasidone 160 mg/day
Number of subjects: 64
Study 17685744 — intervention group
Group type: COMPARATOR
Intervention: Sertraline monotherapy
Number of subjects: 64
Study 15164103 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrient supplementation containing omega-3 fatty acids (1.4 g EPA, 0.211 g DHA, 0.5 g GLA) and micronutrients
Number of subjects: 66
Study 15164103 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 11477493 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment (0.15 IU/kg body weight/week)
Number of subjects: 18
Study 11477493 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 18
Study 9097063 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 33
Study 9097063 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 33
Study 9097063 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 33
Study 7953882 — intervention group
Group type: EXPERIMENTAL
Intervention: Dan Jeon breathing method training group
Number of subjects: 0
Study 2956040 — intervention group
Group type: EXPERIMENTAL
Intervention: semisynthetic human NPH insulin
Number of subjects: 22
Study 2956040 — intervention group
Group type: COMPARATOR
Intervention: porcine NPH insulin
Number of subjects: 22
Study 29696296 — intervention group
Group type: EXPERIMENTAL
Intervention: Paleolithic diet (PD)
Number of subjects: 32
Study 29696296 — intervention group
Group type: COMPARATOR
Intervention: Paleolithic diet and exercise (PD-EX)
Number of subjects: 32
Study 27418629 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 0
Study 27418629 — intervention group
Group type: COMPARATOR
Intervention: Sulfonylurea
Number of subjects: 0
Study 23876935 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous platelet-rich plasma (PRP)
Number of subjects: 21
Study 23876935 — intervention group
Group type: COMPARATOR
Intervention: Dextrose prolotherapy (DP)
Number of subjects: 21
Study 23712007 — intervention group
Group type: EXPERIMENTAL
Intervention: Lightwand-guided nasotracheal intubation
Number of subjects: 116
Study 23712007 — intervention group
Group type: COMPARATOR
Intervention: Blind nasal intubation
Number of subjects: 116
Study 19458534 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifrontal ultrabrief ECT
Number of subjects: 48
Study 19458534 — intervention group
Group type: COMPARATOR
Intervention: Unilateral ultrabrief ECT
Number of subjects: 48
Study 19458534 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifrontal and Unilateral ultrabrief ECT
Number of subjects: 48
Study 19142373 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training Group (RTG)
Number of subjects: 20
Study 19142373 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 20
Study 16608440 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg
Number of subjects: 20
Study 12601301 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine (300 mg/m2), Paclitaxel (70 mg/m2), Carboplatin (AUC 5)
Number of subjects: 37
Study 11713946 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 15 mg daily (LAN 15)
Number of subjects: 849
Study 11713946 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg daily (LAN 30)
Number of subjects: 849
Study 11713946 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine 150 mg twice a day (RAN 150)
Number of subjects: 849
Study 9165379 — intervention group
Group type: EXPERIMENTAL
Intervention: Amisulpride (50 mg/daily)
Number of subjects: 219
Study 9165379 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine (100 mg/daily)
Number of subjects: 219
Study 9165379 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 219
Study 7705093 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone 50 mg followed by 25 mg every 12 hours up to 150 mg + misoprostol 600 micrograms (Group 1)
Number of subjects: 600
Study 7705093 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone 50 mg followed by 25 mg every 12 hours up to 150 mg + PG05 1 mg vaginal suppository (Group 2)
Number of subjects: 600
Study 7705093 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone 200 mg + misoprostol 600 micrograms (Group 3)
Number of subjects: 600
Study 3598866 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressed confederates
Number of subjects: 144
Study 3598866 — intervention group
Group type: COMPARATOR
Intervention: Anxious confederates
Number of subjects: 144
Study 3598866 — intervention group
Group type: COMPARATOR
Intervention: Normal confederates
Number of subjects: 144
Study 30439866 — intervention group
Group type: EXPERIMENTAL
Intervention: Parecoxib pump (PUPA group)
Number of subjects: 124
Study 30439866 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl (FEN group)
Number of subjects: 124
Study 30439866 — intervention group
Group type: COMPARATOR
Intervention: Intravenous parecoxib (IVPA group)
Number of subjects: 124
Study 28189475 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprostadil treatment twice daily for 4 weeks
Number of subjects: 840
Study 28189475 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment twice daily for 4 weeks
Number of subjects: 840
Study 25183687 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium (18 μg once daily) plus Indacaterol (150 μg once daily)
Number of subjects: 46
Study 25183687 — intervention group
Group type: COMPARATOR
Intervention: Advair(®) (50/250 μg twice daily)
Number of subjects: 46
Study 23212243 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous recombinant tissue plasminogen activator (rt‐PA) for the treatment of acute stroke
Number of subjects: 48
Study 21255498 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal high-flow (NHF) oxygen therapy
Number of subjects: 60
Study 21255498 — intervention group
Group type: COMPARATOR
Intervention: Standard high-flow face mask (HFFM) oxygen therapy
Number of subjects: 60
Study 17532637 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral patella taping
Number of subjects: 12
Study 17532637 — intervention group
Group type: EXPERIMENTAL
Intervention: Patellofemoral bracing
Number of subjects: 12
Study 17532637 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 12
Study 16023780 — intervention group
Group type: EXPERIMENTAL
Intervention: Full thickness suturing technique
Number of subjects: 78
Study 16023780 — intervention group
Group type: COMPARATOR
Intervention: Split suturing technique
Number of subjects: 78
Study 12921941 — intervention group
Group type: COMPARATOR
Intervention: Combined control arm for many trials
Number of subjects: 0
Study 12921941 — intervention group
Group type: COMPARATOR
Intervention: Several randomisations at the same up-front time point
Number of subjects: 0
Study 10849039 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A, 25 U
Number of subjects: 123
Study 10849039 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A, 75 U
Number of subjects: 123
Study 10849039 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 123
Study 9167811 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumatic leg brace (Aircast)
Number of subjects: 18
Study 9167811 — intervention group
Group type: COMPARATOR
Intervention: Traditional treatment (rest and gradual return to activity)
Number of subjects: 18
Study 30251100 — intervention group
Group type: EXPERIMENTAL
Intervention: Meniscal repair concurrent with ACL reconstruction
Number of subjects: 44
Study 28264824 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised 1-hour aerobic and resistance exercise (twice per week for 18 weeks)
Number of subjects: 237
Study 28264824 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 237
Study 26255514 — intervention group
Group type: EXPERIMENTAL
Intervention: Catgut implantation
Number of subjects: 45
Study 26255514 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture
Number of subjects: 45
Study 22785003 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS followed by treadmill training
Number of subjects: 20
Study 22785003 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS followed by treadmill training
Number of subjects: 20
Study 21693037 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole (2.5 mg/day) + Norethisterone acetate (2.5 mg/day)
Number of subjects: 35
Study 21693037 — intervention group
Group type: COMPARATOR
Intervention: Letrozole (2.5 mg/day) + Triptorelin (11.25 mg every 3 months)
Number of subjects: 35
Study 21693037 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole + Norethisterone acetate
Number of subjects: 35
Study 21693037 — intervention group
Group type: COMPARATOR
Intervention: Letrozole + Triptorelin
Number of subjects: 35
Study 18507668 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchodilation (BSL)
Number of subjects: 47
Study 18507668 — intervention group
Group type: COMPARATOR
Intervention: Baseline VDT values
Number of subjects: 47
Study 15876834 — intervention group
Group type: EXPERIMENTAL
Intervention: MD HDF
Number of subjects: 20
Study 14615107 — intervention group
Group type: COMPARATOR
Intervention: ACE inhibitors
Number of subjects: 162341
Study 14615107 — intervention group
Group type: COMPARATOR
Intervention: Calcium antagonists
Number of subjects: 162341
Study 14615107 — intervention group
Group type: COMPARATOR
Intervention: Lower blood pressure goals
Number of subjects: 162341
Study 14615107 — intervention group
Group type: COMPARATOR
Intervention: ARB-based regimens
Number of subjects: 162341
Study 14615107 — intervention group
Group type: COMPARATOR
Intervention: Diuretics or beta blockers
Number of subjects: 162341
Study 10668157 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular progesterone (50 mg/day)
Number of subjects: 156
Study 10668157 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal gel progesterone (90 mg/day)
Number of subjects: 156
Study 10668157 — intervention group
Group type: COMPARATOR
Intervention: Control group (no progesterone supplementation)
Number of subjects: 156
Study 8684199 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin (40 mg, once daily for 21 days)
Number of subjects: 179
Study 8684199 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 179
Study 1832883 — intervention group
Group type: EXPERIMENTAL
Intervention: Folinic acid rescue dose of less than 15 mg/m2
Number of subjects: 71
Study 1832883 — intervention group
Group type: COMPARATOR
Intervention: Folinic acid rescue dose of 15 mg/m2 (75 mg/m2)
Number of subjects: 71